Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




“Virtual Slides” Reveal Disease Tissue in 3D

By LabMedica International staff writers
Posted on 07 May 2012
A fast, user-friendly system has been developed for examining tissue samples in “virtual” 3D images. More...
The novel digital scanning 3D reconstruction system produces high-resolution, multicolored images that can be rotated and examined from any angle.

Computing experts and medical researchers at the University of Leeds (Leeds, UK) have combined efforts to developed this technology as a particularly useful tool for histopathology researchers and potentially also for clinical practice, as medical imaging technology provides even higher resolution images of tissue.

Viewing tissue in 3D enables more in-depth understanding of tissue shape characteristics in ways not possible with conventional methods. Currently, hospital pathologists and medical researchers cut tissue samples into ultra-thin slices and routinely examine these by hand, one-by-one, on a microscope. This is a labor-intensive process - a single slide can contain several hundred thousand cells. To perform a 3D-like analysis, users would need to look at hundreds of different 2D sections - something that would be prohibitively expensive and time-consuming.

In contrast, the system developed at the University of Leeds requires almost no extra manual input once the tissue has been cut and mounted onto glass slides. An automated system turns batches of the slides into high-resolution digital images, which are then aligned using image registration software. Users, without input from computing specialists, can then study these virtual blocks of tissue in 3D and zoom in on particular areas of interest.

The researchers have now tested the system on eight different types of tissue, using more than 13,000 virtual slides to create around 400 separate 3D volumes. The system and selected case studies, including examples of liver disease, cancer, and embryology, are described in the May 2012 issue of the American Journal of Pathology.

This new approach to digital 3D reconstruction reveals more detailed information about disease processes - information that could be used to develop new therapies or explain why conventional treatments are not working. "Having a 3D view can often make a real difference," said Dr. Derek Magee, from the University of Leeds School of Computing, where the system’s software was developed. "For instance, if you want to understand how a system of blood vessels supplying a tumor connects up, you really need to see that in 3D, not as a series of separate 2D sections."

Related Links:

University of Leeds
Sample 3D images


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.